EACR-AACR Basic and Translational Research Conference
In partnership with SIC (Società Italiana di Cancerologia)

Immune Responses & DNA Repair - Cancer Fields Converging



The European Association for Cancer Research (EACR), American Association for Cancer Research (AACR) and Società Italiana di Cancerologia (SIC) are proud to announce this new joint Basic and Translational Research Conference that gathers top experts in the fields of Immunology and DNA Damage in Florence, Italy to discuss the molecular mechanisms laying at the convergence of these two research fields and how they can be exploited to treat cancer.


The integrity of DNA molecules is vital for proper cellular function, yet it is under constant assault from environmental and metabolic DNA damaging agents. Failure to maintain faithful DNA replication and as such genome stability and integrity leads to DNA lesions and mutations that are a driving factor in tumour initiation and progression. Cancer development is further modulated by the immune response.

More recent research has uncovered a role for DNA repair mechanisms beyond tumorigenesis. It is now known that DNA repair is at the core of regulating the balance between tumour progression and immune response, and as such can predict the efficacy of immunotherapy.

Target Audience

The target audience for this conference is basic and translational scientists, both senior and young investigators with an interest in DNA damage and repair mechanisms and/ or Cancer Immunology and Immunotherapy, as well as clinicians with an interest in cancer immunotherapy including those involved in the development of novel therapeutic approaches to treatment.

Topics to be covered:

  • The role of DNA Repair Mechanisms and Immune Response and Evasion in cancer
  • Alterations in DNA Repair and Neoantigens
  • Immunotherapy and Genomic Alterations
  • The use of Artificial Intelligence in Diagnostic and Therapeutics
  • How the DNA Damage Response could be exploited to Identify New Therapeutic Vulnerabilities in Cancer
  • Combining Targeting DNA Repair Pathways and Immune Modulation
  • Synthetic Lethality from Discovery to Clinical Implementation

Scientific Programme Committee


  • Alberto Bardelli (co-Chair), IFOM, Italy
  • Vincenzo Costanzo, IFOM, Italy
  • Caroline Dive, Cancer Research UK Manchester Institute, UK


  • Michael B. Kastan (co-Chair), Duke Cancer Institute, USA
  • Alan D. D'Andrea, Dana-Farber Cancer Institute, USA
  • Karlene Cimprich, Stanford University School of Medicine, USA


  • Nicola Normanno (co-Chair), INT-Fondazione Pascale, Italy
  • Paola Chiarugi, Università degli Studi di Firenze, Italy
  • Gabriella Sozzi, Istituto Nazionale Tumori, Milan, Italy

Key dates

Abstract Submission Deadline
21 November 2022

Bursary Application Deadline
21 November 2022

Early Bird Registration Deadline
13 January 2023

Regular Rate Registration Deadline
28 February 2023

Full Rate Registration Deadline
15 March 2023

Above: the beautiful venue city of Florence

Accreditation Statement

The American Association for Cancer Research (AACR) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education activities for physicians.

Follow along on social media and engage with the event using #EASImmuneResponses

Sorry. You need to upgrade your browser

You are using Internet Explorer 8

This is considered an out of date browser. This website has been developed with modern browsers in mind to allow it to display at its best in a wide variety of viewing situations - including mobile viewing. But we haven't supported older browsers like IE8. Please upgrade to the latest version of Internet Explorer - or try Mozilla Firefox or Google Chrome. Both are excellent browsers.

Thank you.